Literature DB >> 2452357

Interactions of piperidine derivatives with the nicotinic cholinergic receptor complex from Torpedo electric organ.

R S Aronstam1, M W Edwards, J W Daly, E X Albuquerque.   

Abstract

The interactions of eight piperidine derivatives with nicotinic receptor complexes from Torpedo californica electric organ were studied using [125I] alpha-bungarotoxin [( 125I]BGT) as a probe for the acetylcholine binding site and [3H]perhydrohistrionicotoxin [( 3H]H12-HTX) as a probe for a site associated with the receptor-gated ion channel. Cis- and trans-2-methyl-6-n-undecanyl piperidines (MUP), major constituents of fire ant venom, had a high-affinity for [3H]H12-HTX binding sites (Ki = 0.08-0.24 microM), but had no affect on receptor binding. MUP affinity for [3H]H12-HTX binding sites was approximately doubled in the presence of 1 microM carbamylcholine. Introduction of a 2'-hydroxyl group to the undecanyl side channel had little effect on activity of the alkaloid. The analog 2,6- (but not 3,5-) dimethylpiperidine was a moderately active inhibitor of [3H]H12-HTX binding (Ki = 8.8 microM). 2-Methylpiperidine was considerably less active (Ki = 600 microM), although it was more potent than either 3- or 4-methylpiperidine. The affinities of 2,6-dimethylpiperidine and 2-methylpiperidine for [3H]H12-HTX binding sites were decreased in the presence of 1 microM carbamylcholine. Carbamylcholine affinity for the receptor was increased by up to 7 fold in the presence of 10 and 32 microM MUP, but was decreased in the presence of 2,6-dimethylpiperidine and 2-methylpiperidine. The cis- and trans-isomers of MUP were equipotent in producing each of its effects. In these actions, MUP resembles a variety of other compounds derived from 2,6-disubstituted piperidines, including histrionicotoxins, gephyrotoxins and pumiliotoxins.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2452357     DOI: 10.1007/bf00973330

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  19 in total

1.  A study of the desensitization produced by acetylcholine at the motor end-plate.

Authors:  B KATZ; S THESLEFF
Journal:  J Physiol       Date:  1957-08-29       Impact factor: 5.182

2.  Site of action of phencyclidine. IV. Interaction of phencyclidine and its analogues on ionic channels of the electrically excitable membrane and nicotinic receptor: implications for behavioral effects.

Authors:  L G Aguayo; J E Warnick; S Maayani; S D Glick; H Weinstein; E X Albuquerque
Journal:  Mol Pharmacol       Date:  1982-05       Impact factor: 4.436

3.  The ionic channel of the nicotinic acetylcholine receptor is unable to differentiate between the optical antipodes of perhydrohistrionicotoxin.

Authors:  C E Spivak; M A Maleque; K Takahashi; A Brossi; E X Albuquerque
Journal:  FEBS Lett       Date:  1983-11-14       Impact factor: 4.124

4.  Interactions of gephyrotoxin with the acetylcholine receptor-ionic channel complex. I. Blockade of the ionic channel.

Authors:  C Souccar; W A Varanda; J W Daly; E X Albuquerque
Journal:  Mol Pharmacol       Date:  1984-05       Impact factor: 4.436

5.  Interactions of gephyrotoxin with the acetylcholine receptor-ionic channel complex. II. Enhancement of desensitization.

Authors:  C Souccar; W A Varanda; R S Aronstam; J W Daly; E X Albuquerque
Journal:  Mol Pharmacol       Date:  1984-05       Impact factor: 4.436

6.  Alkaloids from dendrobatid frogs: structures of two omega-hydroxy congeners of 3-butyl-5-propylindolizidine and occurrence of 2,5-disubstituted pyrrolidines and a 2,6-disubstituted piperidine.

Authors:  J W Daly; T F Spande; N Whittaker; R J Highet; D Feigl; N Nishimori; T Tokuyama; C W Myers
Journal:  J Nat Prod       Date:  1986 Mar-Apr       Impact factor: 4.050

7.  Interactions of bupivacaine with ionic channels of the nicotinic receptor. Electrophysiological and biochemical studies.

Authors:  S R Ikeda; R S Aronstam; J W Daly; Y Aracava; E X Albuquerque
Journal:  Mol Pharmacol       Date:  1984-09       Impact factor: 4.436

8.  Pumiliotoxin-C and synthetic analogues. A new class of nicotinic antagonists.

Authors:  J E Warnick; P J Jessup; L E Overman; M E Eldefrawi; Y Nimit; J W Daly; E X Albuquerque
Journal:  Mol Pharmacol       Date:  1982-11       Impact factor: 4.436

9.  Histrionicotoxin enhances agonist-induced desensitization of acetylcholine receptor.

Authors:  W Burgermeister; W A Catterall; B Witkop
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

10.  Regulation of [3H]perhydrohistrionicotoxin binding to Torpedo ocellata electroplax by effectors of the acetylcholine receptor.

Authors:  R S Aronstam; A T Eldefrawi; I N Pessah; J W Daly; E X Albuquerque; M E Eldefrawi
Journal:  J Biol Chem       Date:  1981-03-25       Impact factor: 5.157

View more
  5 in total

1.  Non-competitive Inhibition of Nicotinic Acetylcholine Receptors by Ladybird Beetle Alkaloids.

Authors:  Ron L Leong; Hong Xing; Jean-Claude Braekman; William R Kem
Journal:  Neurochem Res       Date:  2014-11-05       Impact factor: 3.996

Review 2.  Nicotinic agonists, antagonists, and modulators from natural sources.

Authors:  John W Daly
Journal:  Cell Mol Neurobiol       Date:  2005-06       Impact factor: 5.046

3.  Nicotinic receptor-elicited sodium flux in rat pheochromocytoma PC12 cells: effects of agonists, antagonists, and noncompetitive blockers.

Authors:  J W Daly; Y Nishizawa; M W Edwards; J A Waters; R S Aronstam
Journal:  Neurochem Res       Date:  1991-04       Impact factor: 3.996

4.  Nicotinic receptor inhibition by Tetraponera ant alkaloids.

Authors:  William R Kem; Kristin Wildeboer; Susan LeFrancois; Ma'an Raja; William Marszalec; Jean-Claude Braekman
Journal:  Cell Mol Neurobiol       Date:  2004-08       Impact factor: 5.046

5.  5,8-disubstituted indolizidines: a new class of noncompetitive blockers for nicotinic receptor-channels.

Authors:  J W Daly; Y Nishizawa; W L Padgett; T Tokuyama; A L Smith; A B Holmes; C Kibayashi; R S Aronstam
Journal:  Neurochem Res       Date:  1991-11       Impact factor: 3.996

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.